Study S003237

A Double-Blind, Randomized, Placebo-Controlled, Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-64565111 in Men and Women With Type 2 Diabetes Mellitus

ClinicalTrials.gov record

Registration

Registration: NCT02862431
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: DOUBLE
Status: TERMINATED
Enrollment: 24
Start: 2016-07-12
Primary completion: 2016-11-29
Lead sponsor: Janssen Research & Development, LLC
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG:JNJ-64565111; DRUG:Placebo
Results posted: FALSE
Secondary identifiers: OTHER:64565111EDI1001; EUDRACT_NUMBER:2016-001084-37; NIH:2016

Registered primary outcomes

Number of Participants With Adverse Events as a Measure of Safety and Tolerability [Up to Day 72]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.